ARHGAP17 and lung carcinoma: Evidence suggested that the overexpression of Rho GTPase Activating Protein 17 (ARHGAP17) inhibit the growth and invasion of CRC cells (including HCT-8 and HCT116) and attenuated lung cancer metastasis by suppressing Wnt/β-catenin signaling (Pan et al., 2018).